The reaction mechanisms of model complexes[p 2 n 2 ]Zr(μ-η 2 -NNH)(μ-H)Zr[p 2 n 2 ], B1 (A7), [p 2 n 2 ](H)Zr(μ-η 2 -NNH)Zr[p 2 n 2 ], B11 (A3), [p 2 n 2 ]Zr(μ-η 2 - cis -HNNH)(μ-H)Zr(H)[p 2 n 2 ], C1 (B3), [p 2 n 2 ](H)Zr(μ-η 2 - cis -HNNH)Zr(H)[p 2 n 2 ], C4 (B13), [p 2 n 2 ](H)Zr(μ-η 2 - trans -HNNH)Zr (H)[p 2 n 2 ], C7 (B21), where [p 2 n 2 ] = [(PH 3 )(NH 2 )], with molecular hydrogen have been studied using density functional theory and compared with those for [p 2 n 2 ]Zr(μ-η 2 -N 2 )Zr[p 2 n 2 ], A1. The addition of a H 2 molecule to B1 ( A7 ) (i.e., the addition of the second H 2 to A1 ) takes place with a 19.5 kcal/mol barrier, which is about 2 kcal/mol smaller than that for the first H 2 addition A1 + H 2 → A7 reaction. From B3, product of B1 + H 2, the process proceeds via either channel I.a, the reverse reaction B3 → B1 + H 2, or/and channel I.b, the dihydrogen elimination B3 → [p 2 n 2 ]Zr(μ-η 2 - cis -HNNH)Zr[p 2 n 2 ] ( A15 ) + H 2, with barriers of 11.7 and 21.5 kcal/mol, respectively. Since addition of the first H 2 to A1 is known to occur at laboratory conditions, one predicts that the addition of the H 2 to B1 ( A7 ) will also be feasible under proper experimental conditions. Once A15 is produced, reaction leads to [p 2 n 2 ]Zr(μ-NH)(μ-NH 2 )(μ-H)Zr[p 2 n 2 ] ( B8 ) via formation of [p 2 n 2 ]Zr(μ-NH) 2 Zr[p 2 n 2 ], A17, which was kinetically unreachable by A1 + H 2 because of a very high barrier separating it from A7 . Addition of H 2 to the intermediate complex B11 (A3) leads to B13, where the N−H bonds are located cis to each other. Subsequently, B13 most likely rearranges to complex B3 and follows the reactions of B3 . Addition of the third H 2 molecule to A1 is found to be kinetically less favorable than the first two.
No takes yet. Share an insight, caveat, or question.
Basch et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: